1.Marschall J, Mermel LA, Classen D, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29(suppl 1):S22–S30.
2.Yokoe DS, Anderson DJ, Berenholtz SM, et al. Introduction to “A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates.” Infect Control Hosp Epidemiol 2014;35(5):455–459.
3.Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 2006;81(9):1159–1171.
4.Esteve F, Pujol M, Limon E, et al. Bloodstream infection related to catheter connections: a prospective trial of two connection systems. J Hosp Infect 2007;67(l):30–34.
5.Climo M, Diekema D, Warren DK, et al. Prevalence of the use of central venous access devices within and outside of the intensive care unit: results of a survey among hospitals in the Prevention Epicenter Program of the Centers for Disease Control and Prevention. Infect Control Hosp Epidemiol 2003;24(12): 942–945.
6.Vonberg RP, Behnke M, Geffers C, et al. Device-associated infection rates for non-intensive care unit patients. Infect Control Hosp Epidemiol 2006;27(4):357–361.
7.Marschall J, Leone C, Jones M, Nihill D, Fraser VJ, Warren DK. Catheter-associated bloodstream infections in general medical patients outside the intensive care unit: a surveillance study. Infect Control Hosp Epidemiol 2007;28(8):905–909.
8.Vital signs: central line-associated blood stream infections—United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep 2011;60(8):243–248.
9.Kallen AJ, Patel PR, O’Grady NP. Preventing catheter-related bloodstream infections outside the intensive care unit: expanding prevention to new settings. Clin Infect Dis 2010;51(3): 335–341
10.Zingg W, Sandoz L, Inan C, et al. Hospital-wide survey of the use of central venous catheters, J Hosp Infect 2011;77(4):304–308.
11.Xue H, Ix JH, Wang W, et al. Hemodialysis access usage patterns in the incident dialysis year and associated catheter-related complications. Am J Kidney Dis 2013;61(1):123–130
12.Loftus RW, Brown JR, Koff MD, et al. Multiple reservoirs contribute to intraoperative bacterial transmission. Anesth Analg 2012;114(6):1236–1248.
13.Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994;271(20):1598–1601.
14.Digiovine B., Chenoweth C, Watts C, Higgins M.The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999;160(3):976–181.
15.Renaud B, Brun-Buisson C. Outcomes of primary and catheter-related bacteremia: a cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 2001;163(7):1584–1590.
16.Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 2001;136(2):229–234.
17.Warren DK, Quadir WW, Hollenbeak CS, Elward AM, Cox MJ, Fraser VJ. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med 2006;34(8):2084–2089.
18.Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000;132(5):391–402.
19.Elward AM, Hollenbeak CS, Warren DK, Fraser VJ. Attributable cost of nosocomial primary bloodstream infection in pediatric intensive care unit patients. Pediatrics 2005;115 (4): 868–872
20.Mermel LA. Infections caused by intravascular devices. In: Pfeiffer JA, ed. APIC Text of Infection Control and Epidemiology. 2nd ed. St. Louis: Mosby, 2000:30–38
21.Almuneef MA, Memish ZA, Balkhy HH, Hijazi O, Cunningham G, Francis C.Rate, risk factors and outcomes of catheter-related bloodstream infection in a paediatric intensive care unit in Saudi Arabia. J Hosp Infect 2006;62(2):207–213.
22.Alonso-Echanove J, Edwards JR, Richards MJ, et al. Effect of nurse staffing and antimicrobial-impregnated central venous catheters on the risk for bloodstream infections in intensive care units. Infect Control Hosp Epidemiol 2003;24(12):916–925.
23.Lorente L, Henry C, Martin MM, Jimenez A, Mora ML. Central venous catheter-related infection in a prospective and observational study of 2,595 catheters. Crit Care 2005;9 (6):R631–R635
24.Rey C, Alvarez F, De-La-Rua V, et al. Intervention to reduce catheter-related bloodstream infections in a pediatric intensive care unit. Intensive Care Med 2011;37(4):678–685.
25.Lorente L, Jimenez A, Naranjo C, et al. Higher incidence of catheter-related bacteremia in jugular site with tracheostomy than in femoral site. Infect Control Hosp Epidemiol 2010;31 (3): 311–313
26.Fridkin SK, Pear SM, Williamson TH, Galgiani JN, Jarvis WR. The role of understaffing in central venous catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 1996; 17(3): 150–158.
27.Cimiotti JP, Haas J, Saiman L, Larson EL. Impact of staffing on bloodstream infections in the neonatal intensive care unit. Arch Pediatr Adolesc Med 2006;160(8):832–836.
28.Merrer J, De Jonghe B, Golliot F, et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 2001;286(6):700–707.
29.Raad I, Darouiche R, Dupuis J, et al; Texas Medical Center Catheter Study Group. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. Ann Intern Med 1997;127(4):267–274.
30.Hanna H, Benjamin R, Chatzinikolaou I, et al. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. J Clin Oncol 2004;22(15):3163–3171.
32.Niedner MF. The harder you look, the more you find: catheter-associated bloodstream infection surveillance variability. Am J Infect Control 2010;38(8):585–595.
33.Lin MY, Hota B, Khan YM, et al. Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates. JAMA 2010;304(18):2035–2041.
34.Tomlinson D, Mermel LA, Ethier MC, Matlow A, Gillmeister B, Sung L.Defining bloodstream infections related to central venous catheters in patients with cancer: a systematic review. Clin Infect Dis 2011;53(7):697–710.
35.Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;49(l):l–45
36.O’Grady NP, Alexander M, Dellinger EP, et al; Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep 2002;51(RR-10):l–29
37.O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011;52 (9):el62–el93
39.Saint S.Prevention of intravascular catheter-associated infections. In: Making Health Care Safer. Agency for Healthcare Research and Quality, 2001. http://www.ahrq.gov/clinic/ptsafety/, chapter 16. March 11, 2014
40.Huang EY, Chen C, Abdullah F, et al. Strategies for the prevention of central venous catheter infections: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg 2011;46 (10): 2000–2011.
42.Association for Professionals in Infection Control and Epidemiology (APIC). Guide to the Elimination of Catheter-Related Bloodstream Infections. Chicago: APIC, 2009
43.Infusion Nurses Society. Infusion nursing standards of practice. J Infus Nurs 2011;S34
44.Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355(26):2725–2732.
45.Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004;32(10):2014–2020.
46.Reduction in central line-associated bloodstream infections among patients in intensive care units—Pennsylvania, April 2001-March 2005. MMWR Morb Mortal Wkly Rep 2005; 54(40): 1013–1016.
47.Kim JS, Holtom P, Vigen C.Reduction of catheter-related bloodstream infections through the use of a central venous line bundle: epidemiologies and economic consequences. Am J Infect Control 2011;39(8):640–646.
48.Halton KA, Cook D, Paterson DL, Safdar N, Graves N.Cost-effectiveness of a central venous catheter care bundle. PLoS ONE 2010;5 (9):el2815
49.Helder O, van den Hoogen A, de Boer C, van Goudoever J, Verboon-Maciolek M, Kornelisse R.Effectiveness of non-pharmacological interventions for the prevention of bloodstream infections in infants admitted to a neonatal intensive care unit: a systematic review. Int J Nurs Stud 2013;50(6):819–831.
50.Pronovost PJ, Goeschel CA, Colantuoni E, et al. Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: observational study. BMJ 2010;340: c309
51.Pronovost PJ, Berenholtz SM, Goeschel CA, et al. Creating high reliability in health care organizations. Health Serv Res 2006; 41(4 pt 2): 1599–1617.
52.Furuya EY, Dick A, Perencevich EN, Pogorzelska M, Goldmann D, Stone PW. Central line bundle implementation in US intensive care units and impact on bloodstream infections. PLoS ONE 2011;6 (1):e15452
53.Guerin K, Wagner J, Rains K, Bessesen M.Reduction in central line-associated bloodstream infections by implementation of a postinsertion care bundle. Am J Infect Control 2010;38 (6): 430–433.
54.Miller MR, Griswold M, Harris JM 2nd, et al. Decreasing PICU catheter-associated bloodstream infections: NACHRI’s quality transformation efforts. Pediatrics 2010;125(2):206–213.
55.Miller MR, Niedner MF, Huskins WC, et al. Reducing PICU central line-associated bloodstream infections: 3-year results. Pediatrics 2011;128 (5):el077–el083
56.Sherertz RJ, Ely EW, Westbrook DM, et al. Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med 2000;132(8):641–648.
57.Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D.Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000;355(9218):1864–1868.
58.Coopersmith CM, Rebmann TL, Zack JE, et al. Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit. Crit Care Med 2002;30(l): 59–64.
59.Warren DK, Zack JE, Cox MJ, Cohen MM, Fraser VJ. An educational intervention to prevent catheter-associated bloodstream infections in a nonteaching, community medical center. Crit Care Med 2003;31(7):1959–1963.
60.Warren DK, Zack JE, Mayfield JL, et al. The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU. Chest 2004; 126(5): 1612–1618.
61.Lobo RD, Levin AS, Oliveira MS, et al. Evaluation of interventions to reduce catheter-associated bloodstream infection: continuous tailored education versus one basic lecture. Am J Infect Control 2010;38(6):440–448.
62.Cherry MG, Brown JM, Neal T, Ben Shaw N.What features of educational interventions lead to competence in aseptic insertion and maintenance of CV catheters in acute care? BEME Guide 15. Med Teach 2010;32(3):198–218.
63.Joint Commission on Accreditation of Healthcare Organizations. Assessing Hospital Staff Competence. Oakbrook Terrace, IL: Joint Commission Resources, 2007
64.Barsuk JH, Cohen ER, Feinglass J, McGaghie WC, Wayne DB. Use of simulation-based education to reduce catheter-related bloodstream infections. Arch Intern Med 2009;169(15):1420–1423.
65.Khouli H, Jahnes K, Shapiro J, et al. Performance of medical residents in sterile techniques during central vein catheterization: randomized trial of efficacy of simulation-based training. Chest 2011;139(l): 80–87.
66.Ma IW, Brindle ME, Ronksley PE, Lorenzetti DL, Sauve RS, Ghali WA. Use of simulation-based education to improve outcomes of central venous catheterization: a systematic review and meta-analysis. Acad Med 2011;86 (9): 1137–1147.
67.Bleasdale SC, Trick WE, Gonzalez IM, Lyles RD, Hayden MK, Weinstein RA. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 2007;167(19):2073–2079.
68.O’Horo JC, Silva GL, Munoz-Price LS, Safdar N.The efficacy of daily bathing with chlorhexidine for reducing healthcare-associated bloodstream infections: a meta-analysis. Infect Control Hosp Epidemiol 2012;33(3):257–267.
69.Montecalvo MA, McKenna D, Yarrish R, et al. Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability. Am J Med 2012; 125(5): 505–511.
70.Milstone AM, Elward A, Song X, et al. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicenter, cluster-randomised, crossover trial. Lancet 2013; 381(9872): 1099–1106.
71.Munoz-Price LS, Hota B, Stemer A, Weinstein RA. Prevention of bloodstream infections by use of daily chlorhexidine baths for patients at a long-term acute care hospital. Infect Control Hosp Epidemiol 2009;30(11):1031–1035.
72.Medina A, Serratt T, Pelter M, Brancamp T.Decreasing central line-associated bloodstream infections in the non-ICU population. J Nurs Care Qual 2014;29(2):133–140.
73.Tamma PD, Aucott SW, Milstone AM. Chlorhexidine use in the neonatal intensive care unit: results from a national survey. Infect Control Hosp Epidemiol 2010;31(8):846–849.
74.Bryant KA, Zerr DM, Huskins WC, Milstone AM. The past, present, and future of healthcare-associated infection prevention in pediatrics: catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 2010;31(suppl 1):S27–S31.
75.Chapman AK, Aucott SW, Milstone AM. Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant. J Pennatol 2012;32(l): 4–9.
76.Andersen C, Hart J, Vemgal P, Harrison C.Prospective evaluation of a multi-factorial prevention strategy on the impact of nosocomial infection in very-low-birthweight infants. J Hosp Infect 2005;61(2):162–167.
77.Taylor T, Massaro A, Williams L, et al. Effect of a dedicated percutaneously inserted central catheter team on neonatal catheter-related bloodstream infection. Adv Neonatal Care 2011; 11(2): 122–128.
78.Garland JS, Alex CP, Uhing MR, Peterside IE, Rentz A, Harris MC. Pilot trial to compare tolerance of chlorhexidine gluconate to povidone-iodine antisepsis for central venous catheter placement in neonates. J Perinatol 2009;29(12):808–813.
79.Curry S, Honeycutt M, Goins G, Guliam C.Catheter-associated bloodstream infections in the NICU: getting to zero. Neonatal Netw 2009;28(3):151–155.
80.Garland JS, Alex CP, Mueller CD, et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001;107(6):1431–1436.
81.Tsuchida T, Makimoto K, Toki M, Sakai K, Onaka E, Otani Y.The effectiveness of a nurse-initiated intervention to reduce catheter-associated bloodstream infections in an urban acute hospital: an intervention study with before and after comparison. Int J Nurs Stud 2007;44(8):1324–1333.
82.Gozu A, Clay C, Younus F.Hospital-wide reduction in central line-associated bloodstream infections: a tale of two small community hospitals. Infect Control Hosp Epidemiol 2011;32 (6): 619–622.
83.Occupational Health and Safety Administration, US Department of Labor, http://www.osha.gov. March 11, 2014.
84.Yilmaz G, Koksal I, Aydin K, Caylan R, Sucu N, Aksoy F.Risk factors of catheter-related bloodstream infections in parenteral nutrition catheterization. J PEN J Parenter Enterai Nutr 2007; 31(4): 284–287.
85.Boyce JM, Pittet D; Society for Healthcare Epidemiology of America, Association for Professionals in Infection Control, Infectious Diseases Society of America. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR Recomm Rep 2002;51(RR-16):l–45
86.Rosenthal VD, Guzman S, Safdar N.Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina. Am J Infect Control 2005;33(7):392–397.
87.Capretti MG, Sandri F, Tridapalli E, Galletti S, Petracci E, Faldella G.Impact of a standardized hand hygiene program on the incidence of nosocomial infection in very low birth weight infants. Am J Infect Control 2008;36(6):430–435.
88.Goetz AM, Wagener MM, Miller JM, Muder RR. Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol 1998; 19(ll): 842–845.
89.Parienti JJ, du Chevron D, Timsit JF, et al. Meta-analysis of subclavian insertion and nontunneled central venous catheter-associated infection risk reduction in critically ill adults. Crit Care Med 2012;40(5):1627–1634.
90.Ge X, Cavallazzi R, Li C, Pan SM, Wang YW, Wang FL. Central venous access sites for the prevention of venous thrombosis, stenosis and infection. Cochrane Database Syst Rev 2012;(3): CD004084
91.Parienti JJ, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 2008;299(20):2413–2422.
92.Timsit JF, Bouadma L, Mimoz O, et al. Jugular versus femoral short-term catheterization and risk of infection in intensive care unit patients: causal analysis of two randomized trials. Am J Respir Crit Care Med 2013;188(10):1232–1239.
93.de Jonge RC, Polderman KH, Gemke RJ. Central venous catheter use in the pediatric patient: mechanical and infectious complications. Pediatr Crit Care Med 2005;6(3):329–339.
94.Marik PE, Flemmer M, Harrison WThe risk of catheter-related bloodstream infection with femoral venous catheters as compared to subclavian and internal jugular venous catheters: a systematic review of the literature and meta-analysis. Crit Care Med 2012;40(8):2479–2485.
95.Lorente L, Jimenez A, Roca I, Martin MM, Mora ML. Influence of tracheostomy on the incidence of catheter-related bloodstream infection in the catheterization of jugular vein by posterior access. Eur J Clin Microbiol Infect Dis 2011;30 (9): 1049–1051.
96.Safdar N, Maki DG. Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients. Chest 2005;128(2):489–495.
97.Chopra V, Anand S, Krein SL, Chenoweth C, Saint S.Bloodstream infection, venous thrombosis, and peripherally inserted central catheters: reappraising the evidence. Am J Med 2012; 125(8): 733–741.
98.Ajenjo MC, Morley JC, Russo AJ, et al. Peripherally inserted central venous catheter-associated bloodstream infections in hospitalized adult patients. Infect Control Hosp Epidemiol 2011; 32(2):125–130.
99.Karakitsos D, Labropoulos N, De Groot E, et al. Real-time ultrasound-guided catheterisation of the internal jugular vein: a prospective comparison with the landmark technique in critical care patients. Crit Care 2006;10 (6):R162
100.Hind D, Calvert N, McWilliams R, et al. Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ 2003;327 (7411):361
101.Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 1991;91(3B): 197S–205S
102.Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994;15(4 pt l): 231–238.
103.Hu KK, Lipsky BA, Veenstra DL, Saint S.Using maximal sterile barriers to prevent central venous catheter-related infection: a systematic evidence-based review. Am J Infect Control 2004; 32(3): 142–146.
104.Young EM, Commiskey ML, Wilson SJ. Translating evidence into practice to prevent central venous catheter-associated bloodstream infections: a systems-based intervention. Am J Infect Control 2006;34(8):503–506.
105.Ishikawa Y, Kiyama T, Haga Y, et al. Maximal sterile barrier precautions do not reduce catheter-related bloodstream infections in general surgery units: a multi-institutional randomized controlled trial. Ann Surg 2010;251(4):620–623.
106.Burrell AR, McLaws ML, Murgo M, Calabria E, Panile AC, Herkes R.Aseptic insertion of central venous lines to reduce bacteraemia. Med J Aust 2011;194(ll): 583–587.
107.Lee DH, Jung KY, Choi YH. Use of maximal sterile barrier precautions and/or antimicrobial-coated catheters to reduce the risk of central venous catheter-related bloodstream infection. Infect Control Hosp Epidemiol 2008;29(10):947–950.
108.Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991;338(8763):339–343.
109.Garland JS, Buck RK, Maloney P, et al. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neo-nates: a prospective trial. Pediatr Infect Dis J 1995;14(6):510–516.
110.Humar A, Ostromecki A, Direnfeld J, et al. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis 2000;31 (4): 1001–1007.
111.Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S.Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 2002; 136(11): 792–801.
112.Maiwald M, Chan ES. The forgotten role of alcohol: a systematic review and meta-analysis of the clinical efficacy and perceived role of chlorhexidine in skin antisepsis. PLoS ONE 2012; 7(9):e44277
113.Robert J, Fridkin SK, Blumberg HM, et al. The influence of the composition of the nursing staff on primary bloodstream infection rates in a surgical intensive care unit. Infect Control Hosp Epidemiol 2000;21(1):12–17.
114.Stone PW, Mooney-Kane C, Larson EL, et al. Nurse working conditions and patient safety outcomes. Med Care 2007;45 (6): 571–578.
115.Salzman MB, Isenberg HD, Rubin LG. Use of disinfectants to reduce microbial contamination of hubs of vascular catheters. J Clin Microbiol 1993;31(3):475–479.
116.Luebke MA, Arduino MJ, Duda DL, et al. Comparison of the microbial barrier properties of a needleless and a conventional needle-based intravenous access system. Am J Infect Control 1998;26(4):437–441.
117.Casey AL, Worthington T, Lambert PA, Quinn D, Faroqui MH, Elliott TS. A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow needleless connector. J Hosp Infect 2003;54(4):288–293.
118.Munoz-Price LS, Dezfulian C, Wyckoff M, et al. Effectiveness of stepwise interventions targeted to decrease central catheter-associated bloodstream infections. Crit Care Med 2012;40 (5): 1464–1469.
119.Soothill JS, Bravery K, Ho A, Macqueen S, Collins J, Lock P.A fall in bloodstream infections followed a change to 2% chlorhexidine in 70% isopropanol for catheter connection antisepsis: a pediatric single center before/after study on a hemopoietic stem cell transplant ward. Am J Infect Control 2009;37(8):626–630.
120.Hong H, Morrow DF, Sandora TJ, Priebe GRDisinfection of needleless connectors with chlorhexidine-alcohol provides long-lasting residual disinfectant activity. Am J Infect Control 2013;41 (8):e77–e79
121.Rupp ME, Yu S, Huerta T, et al. Adequate disinfection of a split-septum needleless intra vascular connector with a 5-second alcohol scrub. Infect Control Hosp Epidemiol 2012;33 (7): 661–665.
122.Simmons S, Bryson C, Porter S.“Scrub the hub”: cleaning duration and reduction in bacterial load on central venous catheters. Crit Care Nurs Q 2011;34(l): 31–35.
123.Lederle FA, Parenti CM, Berskow LC, Ellingson KJ. The idle intravenous catheter. Ann Intern Med 1992;116(9):737–738.
124.Parenti CM, Lederle FA, Impola CL, Peterson LR. Reduction of unnecessary intravenous catheter use: internal medicine house staff participate in a successful quality improvement project. Arch Intern Med 1994;154(16):1829–1832.
125.Rotz S, Sopirala MM. Assessment beyond central line bundle: audits for line necessity in infected central lines in a surgical intensive care unit. Am J Infect Control 2012;40(l): 88–89.
126.Cload B, Day AG, Han R.Evaluation of unnecessary central venous catheters in critically ill patients: a prospective observational study. Can JAnaesth 2010;57(9):830–835.
127.Seguin P, LavioUe B, Isslame S, Coue A, Malledant Y.Effectiveness of simple daily sensitization of physicians to the duration of central venous and urinary tract catheterization. Intensive Care Med 2010;36 (7): 1202–1206.
128.Faruqi A, Medefindt J, Dutta G, Philip SA, Tompkins D, Carey J.Effect of a multidisciplinary intervention on central line utilization in an acute care hospital. Am J Infect Control 2012; 40(6):e211–e215
129.Maki DG, Stolz SS, Wheeler S, Mermel LA. A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: implications for catheter management. Crit Care Med 1994;22(11):1729–1737.
130.Rasero L, Degl’Innocenti M, Moeali M.Comparison of two different time interval protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized, multicenter study. Haematologica 2000;85:275–279.
131.Timsit JF, Bouadma L, Ruckly S, et al. Dressing disruption is a major risk factor for catheter-related infections. Crit Care Med 2012;40(6):1707–1714.
132.Gillies D, O’Riordan L, Wallen M, Morrison A, Rankin K, Nagy S.Optimal timing for intravenous administration set replacement. Cochrane Database Syst Rev 2005;(4):CD003588
133.Ullman AJ, Cooke ML, Gillies D, et al. Optimal timing for intravascular administration set replacement. Cochrane Database Syst Rev 2013;(9):CD003588
134.Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int 1991;40(5):934–938.
135.Zakrzewska-Bode A, Muytjens HL, Liem KD, Hoogkamp-Korstanje JA. Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters, J Hosp Infect 1995; 31(3): 189–193.
136.Riu S, Ruiz CG, Martinez-Vea A, Peralta C, Oliver JA. Spontaneous rupture of polyurethane peritoneal catheter: a possible deleterious effect of mupirocin ointment. Nephrol Dial Transplant 1998;13(7):1870–1871.
137.Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J.Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol 2003;14(1):169–179.
138.Fong IW. Prevention of haemodialysis and peritoneal dialysis catheter related infection by topical povidone-iodine. Postgrad Med J 1993;69(suppl 3):S15–S17.
139.Battistella M, Bhola C, Lok CE. Long-term follow-up of the Hemodialysis Infection Prevention with Polysporin Ointment (HIPPO) Study: a quality improvement report. Am J Kidney Dis 2011;57 (3): 432–441.
140.James MT, Conley J, Tonelli M, Manns BJ, MacRae J, Hemmelgarn BR. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med 2008; 148(8): 596–605.
141.Gastmeier P, Geffers C, Brandt C, et al. Effectiveness of a nationwide nosocomial infection surveillance system for reducing nosocomial infections. J Hosp Infect 2006;64(l): 16–22.
142.Zingg W, Sax H, Inan C, et al. Hospital-wide surveillance of catheter-related bloodstream infection: from the expected to the unexpected, J Hosp Infect 2009;73(l): 41–46.
144.Edwards JR, Peterson KD, Andrus ML, et al. National Healthcare Safety Network (NHSN) Report, data summary for 2006, issued June 2007. Am J Infect Control 2007;35(5):290–301.
145.Woeltje KF, McMullen KM, Butler AM, Goris AJ, Doherty JA. Electronic surveillance for healthcare-associated central line-associated bloodstream infections outside the intensive care unit. Infect Control Hosp Epidemiol 2011;32(11):1086–1090.
146.Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med 1997;127(4):257–266.
147.Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999;281(3):261–267.
148.Darouiche RO, Raad II, Heard SO, et al; Catheter Study Group. A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 1999;340(l):l–8
149.Hanna HA, Raad II, Hackett B, et al. Antibiotic-impregnated catheters associated with significant decrease in nosocomial and multidrug-resistant bacteremias in critically ill patients. Chest 2003;124(3):1030–1038.
150.McConnell SA, Gubbins PO, Anaissie EJ. Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection? Clin Infect Dis 2003;37(l): 65–72.
151.Rupp ME, Lisco SJ, Lipsett PA, et al. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med 2005;143(8):570–580.
152.Wang H, Huang T, Jing J, et al. Effectiveness of different central venous catheters for catheter-related infections: a network meta-analysis. J Hosp Infect 2010;76(1):1–11.
153.Cherry-Bukowiec JR, Denchev K, Dickinson S, et al. Prevention of catheter-related blood stream infection: back to basics? Surg Infect (Larchmt) 2011;12(l): 27–32.
154.Guleri A, Kumar A, Morgan RJ, Hartley M, Roberts DH. Anaphylaxis to chlorhexidine-coated central venous catheters: a case series and review of the literature. Surg Infect (Larchmt) 2012;13(3):171–174.
155.Levy I, Katz J, Solter E, et al. Chlorhexidine-impregnated dressing for prevention of colonization of central venous catheters in infants and children: a randomized controlled study. Pediatr Infect Dis J 2005;24(8):676–679.
156.Ho KM, Litton E.Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. J Antimicrob Chemother 2006;58 (2): 281–287.
157.Timsit JF, Schwebel C, Bouadma L, et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA 2009;301(12):1231–1241.
158.Ruschulte H, Franke M, Gastmeier P, et al. Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial. Ann Hematol 2009;88(3):267–272.
159.Camins BC, Richmond AM, Dyer KL, et al. A crossover intervention trial evaluating the efficacy of a chlorhexidine-impregnated sponge in reducing catheter-related bloodstream infections among patients undergoing hemodialysis. Infect Control Hosp Epidemiol 2010;31(11):1118–1123.
160.Timsit JF, Mimoz O, Mourvillier B, et al. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med 2012;186(12): 1272–1278.
161.Menyhay SZ, Maki DG. Preventing central venous catheter-associated bloodstream infections: development of an antiseptic barrier cap for needleless connectors. Am J Infect Control 2008;36 (10):S174el–S174e5
162.Oto J, Imanaka H, Konno M, Nakataki E, Nishimura M.A prospective clinical trial on prevention of catheter contamination using the hub protection cap for needleless injection device. Am J Infect Control 2011;39(4):309–313.
163.Sweet MA, Cumpston A, Briggs F, Craig M, Hamadani M.Impact of alcohol-impregnated port protectors and needleless neutral pressure connectors on central line-associated bloodstream infections and contamination of blood cultures in an inpatient oncology unit. Am J Infect Control 2012;40(10):931–934.
164.Wright MO, Tropp J, Schora DM, et al. Continuous passive disinfection of catheter hubs prevents contamination and bloodstream infection. Am J Infect Control 2013;41(l): 33–38.
165.Loftus RW, Brindeiro BS, Kispert DP, et al. Reduction in intraoperative bacterial contamination of peripheral intravenous tubing through the use of a passive catheter care system. Anesth Analg 2012;115(6):1315–1323.
166.Bertini G, Elia S, Ceciarini F, Dani C.Reduction of catheter-related bloodstream infections in preterm infants by the use of catheters with the AglON antimicrobial system. Early Hum Dev 2013;89(l): 21–25.
167.Chelliah A, Heydon KH, Zaoutis TE, et al. Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients. Pediatr Infect Dis J 2007;26(9):816–820.
168.Bhutta A, Gilliam C, Honeycutt M, et al. Reduction of bloodstream infections associated with catheters in paediatric intensive care unit: stepwise approach. BM] 2007;334(7589):362–365.
169.Weber JM, Sheridan RL, Fagan S, Ryan CM, Pasternack MS, Tompkins RG. Incidence of catheter-associated bloodstream infection after introduction of minocycline and rifampin antimicrobial-coated catheters in a pediatric burn population. J Burn Care Res 2012;33(4):539–543.
170.Carratala J, Niubo J, Fernandez-Sevilla A, et al. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Che-mother 1999;43(9):2200–2204.
171.Henrickson KJ, Axtell RA, Hoover SM, et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial, J Clin Oncol 2000;18(6):1269–1278.
172.Safdar N, Maki DG. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin Infect Dis 2006;43(4):474–484.
173.Labriola L, Crott R, Jadoul M.Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. Nephrol Dial Transplant 2008;23(5):1666–1672.
174.Snaterse M, Ruger W, Scholte Op Reimer WJ, Lucas CAntibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. J Hosp Infect 2010;75(1):1–11.
175.Oliveira C, Nasr A, Brindle M, Wales PWEthanol locks to prevent catheter-related bloodstream infections in parenteral nutrition: a meta-analysis. Pediatrics 2012;129(2):318–329.
176.Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M.Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 2008;47(1):83–93.
177.Opilla MT, Kirby DF, Edmond MB. Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. JPEN J Parenter Enterai Nutr 2007;31(4):302–305.
178.Slobbe L, Doorduijn JK, Lugtenburg PJ, et al. Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial. PLoS ONE 2010;5 (5):el0840
179.Cober MP, Kovacevich DS, Teitelbaum DH. Ethanol-lock therapy for the prevention of central venous access device infections in pediatric patients with intestinal failure. J PEN J Parenter Enterai Nutr 2011;35(l): 67–73.
180.Heng AE, Abdelkader MH, Diaconita M, et al. Impact of short term use of interdialytic 60% ethanol lock solution on tunneled silicone catheter dysfunction. Clin Nephrol 2011;75(6):534–541.
181.Hemmelgarn BR, Moist LM, Lok CE, et al. Prevention of dialysis catheter malfunction with recombinant tissue plasmin-ogen activator. N Engl J Med 2011;364(4):303–312.
182.McKee R, Dunsmuir R, Whitby M, Garden OJ. Does antibiotic prophylaxis at the time of catheter insertion reduce the incidence of catheter-related sepsis in intravenous nutrition? J Hosp Infect 1985;6(4):419–425.
183.Ranson MR, Oppenheim BA, Jackson A, Kamthan AG, Scarffe JH. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J Hosp Infect 1990;15(1):95–102.
184.Sandoe JA, Kumar B, Stoddart B, et al. Effect of extended perioperative antibiotic prophylaxis on intravascular catheter colonization and infection in cardiothoracic surgery patients. J Antimicrob Chemother 2003;52(5):877–879.
185.van de Wetering MD, van Woensel JB, Kremer LC, Caron HN. Prophylactic antibiotics for preventing early gram-positive central venous catheter infections in oncology patients: a Cochrane systematic review. Cancer Treat Rev 2005;31(3):186–196.
186.Karanlik H, Kurul S, Saip P, et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single-center prospective randomized trial. Am J Surg 2011;202(1):10–15.
187.Eyer S, Brummitt C, Crossley K, Siegel R, Cerra F.Catheter-related sepsis: prospective, randomized study of three methods of long-term catheter maintenance. CritCareMed 1990;18 (10): 1073–1079.
188.Cobb DK, High KP, Sawyer RG, et al. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N EnglJ Med 1992;327(15):1062–1068.
189.Cook D, Randolph A, Kernerman P, et al. Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med 1997;25(8):1417–1424.
190.Maragakis LL, Bradley KL, Song X, et al. Increased catheter-related bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. Infect Control Hosp Epidemiol 2006;27(l): 67–70.
191.Field K., McFarlane C, Cheng AC, et al. Incidence of catheter-related bloodstream infection among patients with a needleless, mechanical valve-based intravenous connector in an Australian hematology-oncology unit. Infect Control Hosp Epidemiol 2007;28(5):610–613.
192.Salgado CD, Chinnes L, Paczesny TH, Cantey JR. Increased rate of catheter-related bloodstream infection associated with use of a needleless mechanical valve device at a long-term acute care hospital. Infect Control Hosp Epidemiol 2007;28(6):684–688.
193.Rupp ME, Sholtz LA, Jourdan DR, et al. Outbreak of bloodstream infection temporally associated with the use of an in-travascular needleless valve. Clin Infect Dis 2007;44(11):1408–1414.
194.Jarvis WR, Murphy C, Hall KK, et al. Health care-associated bloodstream infections associated with negative- or positive-pressure or displacement mechanical valve needleless connectors. Clin Infect Dis 2009;49(12):1821–1827.
195.Miller JM, Goetz AM, Squier C, Muder RR. Reduction in nosocomial intravenous device-related bacteremias after institution of an intravenous therapy team, J Intraven Nurs 1996; 19(2): 103–106.
196.Soifer NE, Borzak S, Edlin BR, Weinstein RA. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med 1998;158(5):473–477.
197.Koh DB, Gowardman JR, Rickard CM, Robertson IK, Brown A.Prospective study of peripheral arterial catheter infection and comparison with concurrently sited central venous catheters. Crit Care Med 2008;36(2):397–402.
198.Lucet JC, Bouadma L, Zahar JR, et al. Infectious risk associated with arterial catheters compared with central venous catheters. Crit Care Med 2010;38(4):1030–1035.
199.Tokars JI, Klevens RM, Edwards JR, Horan TC. Measurement of the impact of risk adjustment for central line-days on interpretation of central line-associated bloodstream infection rates. Infect Control Hosp Epidemiol 2007;28(9):1025–1029.
200.Klevens RM, Tokars JI, Edwards J, Horan T.Sampling for collection of central line-day denominators in surveillance of healthcare-associated bloodstream infections. Infect Control Hosp Epidemiol 2006;27(4):338–342.
201.Thompson ND, Edwards JR, Bamberg W, et al. Evaluating the accuracy of sampling to estimate central line-days: simplification of the National Healthcare Safety Network surveillance methods. Infect Control Hosp Epidemiol 2013;34(3):221–228.
202.Casey AL, Karpanen TJ, Nightingale P, Cook M, Elliott TS. Microbiological comparison of a silver-coated and a non-coated needleless intravascular connector in clinical use. J Hosp Infect 2012;80(4):299–303.
203.Webster J, Gillies D, O’Riordan E, Sherriff KL, Rickard CM. Gauze and tape and transparent polyurethane dressings for central venous catheters. Cochrane Database Syst Rev 2011;(11): CD003827
204.Batra R, Cooper BS, Whiteley C, Patel AK, Wyncoll D, Edge-worth JD. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2010;50(2):210–217.
205.Bizzarro MJ, Sabo B., Noonan M, Bonfiglio MP, Northrup V, Diefenbach K.A quality improvement initiative to reduce central line-associated bloodstream infections in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2010;31(3):241–248.
206.Sawyer M, Weeks K, Goeschel CA, et al. Using evidence, rigorous measurement, and collaboration to eliminate central catheter-associated bloodstream infections. Crit Care Med 2010;38(suppl 8):S292–S298.
207.Widmer AF, Nettleman M, Flint K, Wenzel RP. The clinical impact of culturing central venous catheters: a prospective study. Arch Intern Med 1992;152(6):1299–1302.
208.Raad II, Baba M, Bodey GP. Diagnosis of catheter-related infections: the role of surveillance and targeted quantitative skin cultures. Clin Infect Dis 1995;20(3):593–597.
209.Pittet D, Wenzel RP. Nosocomial bloodstream infections: secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995;155(11): 1177–1184.
210.Wong ES, Rupp ME, Mermel L, et al. Public disclosure of healthcare-associated infections: the role of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol 2005;26(2):210–212.
211.Aswani MS, Reagan J, Jin L, Pronovost PJ, Goeschel C Variation in public reporting of central line-associated bloodstream infections by state. Am J Med Qual 2011;26(5):387–395.
212.Talbot TR, Bratzier DW, Carneo RM, et al. Public reporting of health care-associated surveillance data: recommendations from the Healthcare Infection Control Practices Advisory Committee. Ann Intern Med 2013;159(9):631–635.
215.Weaver SJ, Lubomksi LH, Wilson RF, Pfoh ER, Martinez KA, Dy SM. Promoting a culture of safety as a patient safety strategy: a systematic review. Ann Intern Med 2013;158(5 pt 2): 369–374.
216.Hatler CW, Mast D, Corderella J, et al. Using evidence and process improvement strategies to enhance healthcare outcomes for the critically ill: a pilot project. Am J Crit Care 2006; 15(6): 549–555.
219.Silow-Carrol S, Edwards JN. Eliminating Central Line Infections and Spreading Success at High-Performing Hospitals. New York: Commonwealth Fund, 2011
220.Huang GC, Newman LR, Schwartzstein RM, et al. Procedural competence in internal medicine residents: validity of a central venous catheter insertion assessment instrument. Acad Med 2009;84(8):1127–1134.
221.Safdar N, Abad C. Educational interventions for prevention of healthcare-associated infection: a systematic review. Crit Care Med 2008;36(3):933–940.
222.Smith JS, Kirksey KM, Becker H, Brown A.Autonomy and self-efficacy as influencing factors in nurses’ behavioral intention to disinfect needleless intravenous systems, J Infus Nurs 2011;34(3):193–200.
223.Faruqi A, Medefindt J, Dutta G, Philip SA, Tompkins D, Carey J.Effect of a multidisciplinary intervention on central line utilization in an acute care hospital. Am J Infect Control 2012; 40(6):e211–e215
224.Warren D, Zack J, Mayfield J, et al. The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU. Chest 2004;126 (5): 1612–1618.
225.Warren DK, Yokoe DS, Climo MW, et al. Preventing catheter-associated bloodstream infections: a survey of policies for insertion and care of central venous catheters from hospitals in the Prevention Epicenter Program. Infect Control Hosp Epidemiol 2006;27 (1): 8–13.
226.Chittick P, Sherertz RJ. Recognition and prevention of nosocomial vascular device and related bloodstream infections in the intensive care unit. Crit Care Med 2010;38(suppl 8):S363–S372.
227.Moureau N, Lamperti M, Kelly LJ, et al. Evidence-based consensus on the insertion of central venous access devices: definition of minimal requirements for training. Br J Anaesth 2013; 110(3): 347–356.
228.Warren DK, Cosgrove SE, Diekema DJ, et al. A multicenter intervention to prevent catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 2006;27(7):662–669.
229.Sannoh S, Clones B, Munoz J, Montecalvo M, Parvez B.A multimodal approach to central venous catheter hub care can decrease catheter-related bloodstream infection. Am J Infect Control 2010;38(6):424–429.
230.Banks CM, Gilmartin H, Fink RM. Education methods for maintaining nursing competency in low-volume, high-risk procedures in the rural setting: bridging the theory to practice gap. J Nurses Staff Dev 2010;26 (3):E1–E7
231.Comer A, Harris AD, Shardell MP, et al. Web-based training improves knowledge about central line bloodstream infections. Infect Control Hosp Epidemiol 2011;32(12):1219–1222.
232.Guembe M, Parez-Parra A, Gómez E, et al. Impact on knowledge and practice of an intervention to control catheter infection in the ICU. Eur J Clin Microbiol Infect Dis 2012;31 (10): 2799–2808.
233.Zack J.Zeroing in on zero tolerance for central line-associated bacteremia. Am J Infect Control 2008;36 (10):S176.el
234.Aboelela SW, Stone PW, Larson EL. Effectiveness of bundled behavioural interventions to control healthcare-associated infections: a systematic review of the literature, J Hosp Infect 2007; 66(2): 101–108.
235.Sherertz R, Ely E, Westbrook D, et al. Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med 2000;132(8):641–648.
236.Walz JM, Memtsoudis SG, Heard SO. Analytic reviews: prevention of central venous catheter bloodstream infections. J Intensive Care Med 2010;25(3):131–138.
237.Rodriguez-Paz JM, Kennedy M, Salas E, et al. Beyond “see one, do one, teach one”: toward a different training paradigm. Qual Saf Health Care 2009;18(l): 63–68.
238.Ahya SN, Barsuk JH, Cohen ER, Tuazon J, McGaghie WC, Wayne DB. Clinical performance and skill retention after simulation-based education for nephrology fellows. Semin Dial 2012;25(4):470–473.
239.Ault MJ, Rosen BT, Ault B.The use of tissue models for vascular access training: phase I of the procedural patient safety initiative. J Gen Intern Med 2006;21(5):514–517.
240.Evans LV, Dodge KL. Simulation and patient safety: evaluative checklists for central venous catheter insertion. Qual Saf Health Care 2010;19(suppl 3):i42–i46
241.Ahlin C, Klang-Söderkvist B, Brundin S, Hellström B, Pettersson k, Johansson E.Implementation of a written protocol for management of central venous access devices: a theoretical and practical education, including bedside examinations. J Infus Nurs 2006;29(5):253–259.
242.Segreti J, Garcia-Houchins S, Górski L, et al. Consensus conference on prevention of central line-associated bloodstream infections: 2009. J Infus Nurs 2011;34(2):126–133.
243.Labeau S, Vereecke A, Vandijck DM, Claes B, Blot SI. Critical care nurses’ knowledge of evidence-based guidelines for preventing infections associated with central venous catheters: an evaluation questionnaire. Am J Crit Care 2008;17(1):65–71.
244.Labeau SO, Vandijck DM, Relio J, et al. Centers for Disease Control and Prevention guidelines for preventing central venous catheter-related infection: results of a knowledge test among 3405 European intensive care nurses. Crit Care Med 2009;37(l): 320–323.
245.Marra AR, Cal RG, Durao MS, et al. Impact of a program to prevent central line-associated bloodstream infection in the zero tolerance era. Am J Infect Control 2010;38(6):434–439.
246.Wheeler DS, Giaccone MJ, Hutchinson N, et al. A hospital-wide quality-improvement collaborative to reduce catheter-associated bloodstream infections. Pediatrics 2011;128 (4):e995–e1004
247.Harting BP, Talbot TR, Dellit TH, et al. University Health-System Consortium quality performance benchmarking study of the insertion and care of central venous catheters. Infect Control Hosp Epidemiol 2008;29(5):440–442.
248.Jeffries HE, Mason W, Brewer M, et al. Prevention of central venous catheter-associated bloodstream infections in pediatric intensive care units: a performance improvement collaborative. Infect Control Hosp Epidemiol 2009;30(7):645–651.
249.Stevens TP, Schulman J.Evidence-based approach to preventing central line-associated bloodstream infection in the NICU. Acta Paediatr Suppl 2012;101(464):11–16.
250.Powers RJ, Wirtschafter DW. Decreasing central line associated bloodstream infection in neonatal intensive care. Clin Perinatol 2010;37(l): 247–272.
251.Rupp ME, Cassling K, Faber H, et al. Hospital-wide assessment of compliance with central venous catheter dressing recommendations. Am J Infect Control 2013;41(1):89–91.
253.Son CH, Daniels TL, Eagan J, et al. Central line-associated bloodstream infection surveillance outside the intensive care unit: a multicenter survey. Infect Control Hosp Epidemiol 2012; 33(9): 869–874.
254.Woeltje KF, McMullen KM, Butler AM, Goris AJ, Doherty JA. Electronic surveillance for healthcare-associated central line-associated bloodstream infections outside the intensive care unit. Infect Control Hosp Epidemiol 2011;32(11):1086–1090.
255.Berhe M, Edmond MB, Bearman G.Measurement and feedback of infection control process measures in the intensive care unit: impact on compliance. Am J Infect Control 2006;34 (8): 537–539.
256.Assanasen S, Edmond M, Bearman G.Impact of 2 different levels of performance feedback on compliance with infection control process measures in 2 intensive care units. Am J Infect Control 2008;36(6):407–413.
257.Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924–926.